WHO世界卫生组织：2024年阿尔茨海默病血液生物标志物诊断的首选产品特性报告（英文版）

Diagnosis is the first step into the care journey. To support a timely and accurate dementia diagnosis, it is critical to develop diagnostic tools, such as blood-based biomarker tests, that can support the health-care workforce in their clinical decision-making, and that can be readily implemented in low-resource settings. WHO Preferred Product Characteristics (PPCs) are technical documents that define the preferred attributes of diagnostic products for regulatory purposes, policy, and programma